Medically reviewed by Dr Amol Bhanushali, thoracic and chest surgeon
Lung cancer treatment in Mumbai almost never begins with a single treatment chosen over the others. It begins with a sequence, decided by a group of specialists before anything starts, because the order in which surgery, chemotherapy and radiation are given changes what each one can achieve. A patient sent for chemotherapy first has not been refused surgery. The plan has simply been built in a different order.
Key insights
- The sequence is the treatment plan: surgery, chemotherapy and radiation are not alternatives to choose between.
- Chemotherapy before surgery is often a surgical strategy: it can shrink a tumour into a safer, smaller operation.
- Resectable is a judgement, not a label: it depends on the tumour, the patient’s lung function and what the surgical team can safely do.
- No single doctor decides this alone: the plan comes out of a multidisciplinary meeting, and that is a safeguard rather than a delay.
Before your next appointment
Write down one question and ask it plainly: “What is the planned order of my treatment, and what has to be true for it to change?” A team that has thought the sequence through can answer that in two minutes. The answer also tells you what the scans at each stage are actually checking for, which makes the waiting considerably easier to sit with.
The week after a lung cancer diagnosis is usually spent trying to work out which treatment is best. That is a reasonable instinct and the wrong question, because it assumes the three main treatments compete with each other.
They do not. Surgery removes disease that can be removed. Chemotherapy and immunotherapy treat disease throughout the body, including cells too small to appear on any scan. Radiation treats a defined area with precision. Most people need more than one, and what genuinely changes the outcome is the order.
This page explains how that order gets decided, who decides it, and why being sent for chemotherapy when you expected an operation is often good news rather than bad.
Why is the order decided before treatment begins?
Because each treatment changes the conditions for the next one.
Surgery changes what imaging can tell you
Once tissue is removed, the baseline scans that chemotherapy response would be measured against no longer exist in the same form. Giving systemic treatment first means the tumour itself becomes the measure of whether that treatment works.
Chemotherapy changes what surgery has to remove
A tumour that shrinks before an operation can convert a large resection into a smaller one, and sometimes converts an inoperable case into an operable one.
Radiation changes the tissue a surgeon works in
Irradiated tissue heals differently. Where radiation is planned alongside surgery, the timing has to account for that rather than being fitted in afterwards.
Which is why the plan comes first
Starting a treatment without the sequence agreed risks closing off an option that would have been available in a different order. This is the single most important thing to understand about the first two weeks.
What does the multidisciplinary meeting actually do?
A group of specialists reviews the case together and agrees a plan before anything is offered to the patient.
Who is usually in the room
A thoracic surgeon, a medical oncologist, a radiation oncologist, a radiologist and a pathologist, with a pulmonologist frequently involved.
Who contributes what
| Specialist | What they assess |
| Thoracic surgeon | Whether the disease can be removed, and by what approach |
| Medical oncologist | What systemic treatment the disease and the patient will respond to |
| Radiation oncologist | Whether a target can be treated precisely, and when |
| Radiologist | What the imaging genuinely shows about extent and spread |
| Pathologist | Tumour type and molecular markers that change drug choice |
What they are deciding
Whether the disease is removable, whether it should be removed first, what the imaging and biopsy actually show, and what the patient’s lungs and general health can tolerate.
Why this is a safeguard rather than a delay
A single specialist naturally sees a case through the lens of their own treatment. A surgeon asked in isolation whether an operation is possible is answering a narrower question than whether an operation is the right first step.
What it means for you as a patient
The plan you are given has already been argued over. If it differs from what you expected, the reason usually sits in a detail of the staging that has not yet been explained to you, and it is entirely reasonable to ask for that explanation.
What makes a tumour resectable?
Resectable means the disease can be removed completely with an acceptable margin, and that the patient can survive and recover from the operation required. Both halves matter.
The tumour half
Size, position, whether it involves major blood vessels or structures that cannot be reconstructed, and whether it has spread beyond what an operation can address.
The patient half
Lung function tests, cardiac fitness, and how much lung tissue can be removed while leaving enough to live comfortably. A tumour that is technically removable in a patient who cannot tolerate the resection is not resectable in practice.
Why the answer can change
Resectability is reassessed after treatment. Disease that was borderline at diagnosis is frequently reassessed after systemic therapy has shrunk it, which is precisely why sequencing exists as a strategy.
Why second opinions matter here more than elsewhere
Resectability depends partly on what a particular surgical team is equipped and willing to do. A case called inoperable at one centre is sometimes operable at another, and that is a genuine difference in capability rather than a difference of opinion.
When does chemotherapy come first?
Treatment given before surgery is called neoadjuvant, and it has moved from an exception to a standard consideration.
What the evidence has shifted towards
A recent narrative review describes a paradigm shift towards neoadjuvant immunotherapy, giving systemic treatment before surgery to address both the primary tumour and micrometastatic disease, using the intact tumour to prime the immune response before it is removed.
Why the intact tumour matters
It gives the team something to measure. The degree to which a tumour responds before surgery is information that simply does not exist if the tumour is removed first.
What the comparison with adjuvant treatment shows
A review of neoadjuvant, perioperative and adjuvant approaches notes that adjuvant chemotherapy alone had a modest impact on survival in early-stage resected disease, while adding immunotherapy across these settings improved outcomes beyond chemotherapy-alone approaches.
What this means in a consultation
Being sent for systemic treatment first is often a sign that the team is planning towards surgery rather than away from it. Ask directly whether surgery remains the goal, because the answer is frequently yes.
When does surgery come first?
| Situation | Usual first step | Why |
| Small, early, clearly localised tumour | Surgery | Removal is definitive and the disease is contained |
| Larger tumour, still localised | Often systemic treatment first | To shrink the tumour and treat unseen disease |
| Involvement of nodes in the centre of the chest | Usually systemic treatment first | Staging changes what surgery can achieve |
| Disease outside the chest | Systemic treatment, surgery rarely | The problem is no longer local |
| Patient unable to tolerate resection | Radiation and systemic treatment | The operation itself carries more risk than benefit |
The early-stage case
Where disease is small, peripheral and clearly confined, removing it first is straightforward and frequently curative. Adjuvant treatment afterwards is then decided on what the pathology shows.
Why pathology after surgery can change the plan
The tissue removed is examined in full, and it sometimes shows more than the scans suggested. Treatment recommended after an operation is a response to that finding rather than a sign the surgery failed.
Where does radiation sit in the sequence?
Radiation is precise and local, which makes it useful in several different positions in a plan.
Instead of surgery
Where a patient cannot safely undergo resection, focused radiation can treat an early tumour definitively.
After surgery
Where pathology shows disease at a margin or in particular nodes, radiation may follow to treat the area that surgery could not fully clear.
Alongside chemotherapy
In disease that is locally advanced but not removable, the two are frequently given together rather than in sequence.
Why it is rarely a straight substitute
Radiation treats what is targeted. It does not provide the complete pathological picture that removing and examining tissue does, which is why surgery remains preferred where it is safely possible.
What does the treatment approach change about recovery?
Minimally invasive against open surgery
Where a resection is required, the approach affects recovery far more than it affects the cancer plan. Options including uniportal VATS and robot-assisted thoracic surgery are chosen on tumour position and patient factors.
When an open approach is the right answer
Complex resections involving the chest wall or major structures need the access that complex open thoracic surgery provides, and choosing it is a clinical decision rather than a fallback.
How prior treatment affects the operation
Operating after systemic therapy is technically different, and a team that routinely does so plans for it. This is worth asking about if your sequence puts chemotherapy first.
What should you ask before agreeing to a plan?
About the sequence
What is the planned order, what is the goal of each step, and what would change it.
About the staging
What stage the disease is, what the staging is based on, and whether any further scan or biopsy would change it.
About the surgery
Whether resection is the goal, what approach is planned, and what happens if the tumour responds better or worse than expected.
About the team
Who reviewed the case, and whether the plan came out of a multidisciplinary discussion. The lung cancer treatment page sets out how cases are assessed and staged here.
The four questions in one place
| Ask | Why it matters |
| What is the planned order | Tells you the strategy rather than the individual treatments |
| What would change it | Tells you what each interim scan is actually checking |
| Is surgery the goal | Separates a sequencing decision from a refusal |
| Who reviewed the case | Confirms the plan came from a multidisciplinary discussion |
Wrapping up
Lung cancer treatment in Mumbai is a sequence rather than a choice between three options, and the sequence is settled before anything begins because each step changes what the next one can do. Chemotherapy first is frequently a surgical strategy. Surgery first is right when disease is contained. Radiation fits in several places depending on what the rest of the plan needs.
Dr Amol Bhanushali brings over 15 years of thoracic surgical experience and a Tata Memorial Hospital thoracic surgery fellowship to that discussion, with cases assessed for resectability against both the tumour and the patient’s own lung function rather than against a standard protocol.
If you have been given a plan you do not fully understand, or told an operation is not possible, bring the scans and the reports and ask for the sequence to be explained properly. Book a consultation to have the plan reviewed.
FAQs
Why has my doctor recommended chemotherapy before surgery?
Usually to shrink the tumour, treat disease too small to see on scans, and measure how the cancer responds while it is still present. It frequently indicates the team is planning towards surgery rather than away from it.
Does chemotherapy first mean my cancer is advanced?
Not necessarily. Neoadjuvant treatment is now a standard consideration in earlier-stage disease that is still removable, and the sequence reflects strategy rather than severity on its own.
Can a tumour called inoperable become operable later?
Yes. Resectability is reassessed after systemic treatment, and disease that was borderline at diagnosis is sometimes removable once it has shrunk. It also depends on what a particular surgical team can safely undertake.
Who decides the order of my treatment?
A multidisciplinary group rather than one doctor, typically including a thoracic surgeon, a medical oncologist, a radiation oncologist, a radiologist and a pathologist, each assessing the case from a different angle before a plan is agreed.
Is surgery always better than radiation for lung cancer?
Not always. Surgery is preferred where it can be done safely because it removes and fully examines the tissue, but focused radiation treats early tumours definitively in patients who cannot tolerate an operation.
Why do I need more treatment after a successful operation?
Because the removed tissue is examined in full and sometimes shows more than the scans indicated. Additional treatment responds to that finding and does not mean the surgery was unsuccessful.